secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2023-08-09T23:59:59+00:00
Accession:  0001213900-23-064786
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oramed to acquire Scilex securities from Sorrento for $105M; provides $100M DIP loan
--------------------------------------------------------------------------------

- Oramed will purchase Scilex common and preferred stock plus warrants from Sorrento for $105M total.
- Consideration includes a dollar-for-dollar credit bid of outstanding obligations under a $100M replacement DIP facility.
- Sorrento is in Chapter 11; transaction subject to Bankruptcy Court approval, auction, and closing by Sept 30, 2023.
- Oramed is providing $100M senior secured super-priority DIP loan to Sorrento and Scintilla at 15% interest.
- Oramed will receive rights to Scilex Series A preferred stock and governance control via proxy and call option.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000121390023064786/0001213900-23-064786-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000121390023064786/ea183023-8k_oramed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-064786

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer